Phocas Financial Corp. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Phocas Financial Corp. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$5,169,000
-18.9%
1,022,708
-1.0%
0.55%
-19.2%
Q2 2019$6,376,000
+19.9%
1,033,328
-9.9%
0.68%
+27.5%
Q1 2019$5,319,000
-25.4%
1,146,292
-32.5%
0.54%
-32.8%
Q4 2018$7,133,000
-34.5%
1,698,249
-2.2%
0.80%
-16.6%
Q3 2018$10,887,000
-23.2%
1,736,386
-1.5%
0.95%
-21.7%
Q2 2018$14,174,000
+6.8%
1,762,978
-0.9%
1.22%
+1.9%
Q1 2018$13,275,000
+55.0%
1,779,524
+23.6%
1.20%
+66.6%
Q4 2017$8,564,000
+77754.5%
1,439,307
-4.1%
0.72%
-22.0%
Q3 2017$11,000
-99.9%
1,500,285
+2.3%
0.92%
+2.2%
Q2 2017$9,959,000
-24.7%
1,466,748
+4.7%
0.90%
-26.5%
Q1 2017$13,228,000
-3.8%
1,401,257
-12.0%
1.22%
+35.4%
Q4 2016$13,750,000
+36.4%
1,591,462
-0.1%
0.90%
+28.6%
Q3 2016$10,084,000
+268.0%
1,593,088
+145.4%
0.70%
+252.0%
Q2 2016$2,740,000
+3.0%
649,295
+6.4%
0.20%
-2.0%
Q1 2016$2,659,000
-31.7%
609,963
-4.0%
0.20%
-33.1%
Q4 2015$3,895,000
+15.4%
635,333
+7.7%
0.30%
+7.0%
Q3 2015$3,374,000
-17.7%
589,919
+7.4%
0.28%
-14.2%
Q2 2015$4,098,000
-45.4%
549,287
-56.3%
0.33%
-44.4%
Q1 2015$7,509,000
-5.2%
1,255,645
+19.9%
0.60%
-13.5%
Q4 2014$7,917,000
+40.0%
1,047,181
-3.9%
0.69%
+36.4%
Q3 2014$5,656,000
+40.8%
1,089,745
+16.9%
0.51%
+44.6%
Q2 2014$4,016,000
+21.9%
931,880
+15.7%
0.35%
+10.4%
Q1 2014$3,295,000
-1.1%
805,595
+28.9%
0.32%
+101.9%
Q4 2013$3,332,000625,0730.16%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders